VIC Regimen Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Advanced Colorectal Cancer
Clinical trial NCT05540951 · UNKNOWN
Trial details
- NCT number
- NCT05540951
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-01
- Primary completion
- 2022-08-30
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.